Whether given prophylactically or therapeutically, Probio-M9 intervention was found to boost the anti-PD-1-based tumor inhibition, not only by enhancing cytotoxicity of CD8+ T cells but also by suppressing the function of Treg cells (65). This evidence concerns the gene CD8A and neoplasm.